WHO ICTRP trial
A clinical study to determine the safety and effectiveness of intracoronary…
JPRN-jRCTb030200001 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-jRCTb030200001 |
|---|---|
| Public title | A clinical study to determine the safety and effectiveness of intracoronary infusion of autologous c-kit-positive cardiac stem cells in Japanese patients with ischemic cardiomyopathy. |
| Scientific title | Japanese OMI treatment with Kit-positive cells for Enhanced Regeneration trial - JOKER trial |
| Primary sponsor | Hosoda Toru |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | 1 |
| Countries | Japan |
| Conditions | Chronic ischemic heart failure Heart Failure;Heart Failure |
| Interventions | Autologous intracoronary single infusion of 1,000,000 cardiac stem cells via cardiac catheter.;Stem Cell Transplantation |
| Registration date | Mar 31, 2020 |
| Target size | 6 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: